You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ)提醒投資者防範不法分子假冒公司名義從事詐騙活動
格隆匯 02-10 17:52

格隆匯2月10日丨重藥控股(000950.SZ)公佈,近期,公司接到投資者反映,有不法分子假冒公司及子公司名義,利用網絡平台,向投資者進行虛假宣傳,實施詐騙,騙取投資者的資金或個人信息。為此,公司鄭重提醒廣大投資者:

一、公司從未上線理財類APP,未開展任何相關眾籌集資業務及銷售理財業務,也從未授權任何個人或單位開展上述業務。

二、公司註冊名稱:重藥控股股份有限公司;英文全稱:C.Q. Pharmaceutical Holding Co., Ltd.;公司官方網站:www.cqphar.com;電子郵箱:000950@cq-p.com.cn;投資者接待專線:023-63910671。

三、公司的相關信息請以公司在證監會指定信息披露媒體和巨潮資訊網(www.cninfo.com.cn)上披露的公吿文件為準。切勿輕信任何其他非正規渠道信息,敬請廣大投資者提高警惕,仔細辨別。

四、公司強烈譴責任何假冒公司及子公司名義欺詐投資者的違法行為,公司保留對以任何方式假冒本公司名義、損害本公司名譽的機關及個人採取法律行動、追究法律責任的權利。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account